{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T14:09:35Z","timestamp":1774706975350,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00192-025-06375-9","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:50:03Z","timestamp":1760367003000},"page":"719-729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Pharmacologic Thromboprophylaxis on Venous Thromboembolism and Bleeding Complications Following Pelvic Organ Prolapse Procedures"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7797-3816","authenticated-orcid":false,"given":"Hope H.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura A.","family":"Schlussel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adonis K.","family":"Hijaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sheyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"4","key":"6375_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ajog.2023.11.1255","volume":"230","author":"LI Lavikainen","year":"2024","unstructured":"Lavikainen LI, Guyatt GH, Kalliala IEJ, Cartwright R, Luomaranta AL, Vernooij RWM, et al. Risk of thrombosis and bleeding in gynecologic noncancer surgery: systematic review and meta-analysis. Am J Obstet Gynecol. 2024;230(4):390\u2013402.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"6375_CR2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/AOG.0000000000000286","volume":"123","author":"JM Wu","year":"2014","unstructured":"Wu JM, Matthews CA, Conover MM, Pate V, Jonsson Funk M. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol. 2014;123(6):1201\u20136.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6375_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jmig.2018.08.025","volume":"26","author":"EM Jorgensen","year":"2019","unstructured":"Jorgensen EM, Hur HC. Venous thromboembolism in minimally invasive gynecologic surgery: a systematic review. J Minim Invasive Gynecol. 2019;26(2):186\u201396.","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"6375_CR4","doi-asserted-by":"publisher","first-page":"268.e1","DOI":"10.1016\/j.ajog.2020.05.020","volume":"223","author":"W Chong","year":"2020","unstructured":"Chong W, Bui AH, Menhaji K. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs. Am J Obstet Gynecol. 2020;223(2):268.e1-268.e26.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"6375_CR5","doi-asserted-by":"publisher","first-page":"510.e1","DOI":"10.1016\/j.ajog.2010.07.021","volume":"203","author":"ER Solomon","year":"2010","unstructured":"Solomon ER, Frick AC, Paraiso MF, Barber MD. Risk of deep venous thrombosis and pulmonary embolism in urogynecologic surgical patients. Am J Obstet Gynecol. 2010;203(5):510.e1-4.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"6375_CR6","doi-asserted-by":"publisher","first-page":"552.e1","DOI":"10.1016\/j.ajog.2014.07.031","volume":"211","author":"MG Mueller","year":"2014","unstructured":"Mueller MG, Pilecki MA, Catanzarite T, Jain U, Kim JY, Kenton K. Venous thromboembolism in reconstructive pelvic surgery. Am J Obstet Gynecol. 2014;211(5):552.e1-6.","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"6375_CR7","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00192-016-2990-z","volume":"27","author":"ED Hokenstad","year":"2016","unstructured":"Hokenstad ED, Habermann EB, Glasgow AE, Occhino JA. Risk of venous thromboembolism in patients undergoing surgery for pelvic organ prolapse. Int Urogynecol J. 2016;27(10):1525\u20138.","journal-title":"Int Urogynecol J"},{"issue":"2 Suppl","key":"6375_CR8","doi-asserted-by":"publisher","first-page":"e227S","DOI":"10.1378\/chest.11-2297","volume":"141","author":"MK Gould","year":"2012","unstructured":"Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e227S-e277S.","journal-title":"Chest"},{"issue":"8","key":"6375_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/0002-9378(84)90632-X","volume":"148","author":"DL Clarke-Pearson","year":"1984","unstructured":"Clarke-Pearson DL, Synan IS, Colemen RE, Hinshaw W, Creasman WT. The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol. 1984;148(8):1051\u20134.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"6375_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/AOG.0000000000004445","volume":"138","author":"DL Clarke-Pearson","year":"2021","unstructured":"Clarke-Pearson DL, Barber EL, Landrum LM. Prevention of venous thromboembolism in gynecologic surgery: ACOG practice bulletin, number 232. Obstet Gynecol. 2021;138(1):e1-15.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"6375_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/AOG.0b013e318232a394","volume":"118","author":"DD Rahn","year":"2011","unstructured":"Rahn DD, Mamik MM, Sanses TVD, Matteson KA, Aschkenazi SO, Washington BB, et al. Venous thromboembolism prophylaxis in gynecologic surgery: a systematic review. Obstet Gynecol. 2011;118(5):1111\u201325.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6375_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/00016348809004178","volume":"67","author":"E Borstad","year":"1988","unstructured":"Borstad E, Urdal K, Handeland G, Abildgaard U. Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery. Acta Obstet Gynecol Scand. 1988;67(2):99\u2013103.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"6375_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1471-0528.1983.tb09307.x","volume":"90","author":"PW Docherty","year":"1983","unstructured":"Docherty PW, Goodman JD, Hill JG, Pickles BG, Boardman J, Taylor CG, et al. The effect of low-dose heparin on blood loss at abdominal hysterectomy. Br J Obstet Gynaecol. 1983;90(8):759\u201363.","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"6375_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ygyno.2007.03.004","volume":"105","author":"MH Einstein","year":"2007","unstructured":"Einstein MH, Pritts EA, Hartenbach EM. Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review. Gynecol Oncol. 2007;105(3):813\u20139.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"6375_CR15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1093\/humrep\/des103","volume":"27","author":"TH Brummer","year":"2012","unstructured":"Brummer TH, Heikkinen A, Jalkanen J, Fraser J, M\u00e4kinen J, Tom\u00e1s E, et al. Pharmaceutical thrombosis prophylaxis, bleeding complications and thromboembolism in a national cohort of hysterectomy for benign disease. Hum Reprod. 2012;27(6):1628\u201336.","journal-title":"Hum Reprod"},{"key":"6375_CR16","unstructured":"PING AI Applied Sciences, Premier Inc (2023) PING AI Healthcare Database: Data that informs and performs (White Paper). https:\/\/offers.pinc-ai.com\/PINC-AI-Healthcare-Database-White-Paper-LP.html"},{"key":"6375_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/1076029619838052","volume":"25","author":"M Cronin","year":"2019","unstructured":"Cronin M, Dengler N, Krauss ES, Segal A, Wei N, Daly M, et al. Completion of the updated caprini risk assessment model (2013 version). Clin Appl Thromb Hemost. 2019;25:1076029619838052.","journal-title":"Clin Appl Thromb Hemost"},{"key":"6375_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67:1\u201348. https:\/\/doi.org\/10.18637\/jss.v067.i01.","journal-title":"J Stat Softw"},{"key":"6375_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/00031305.1980.10483031","volume":"34","author":"SR Searle","year":"1980","unstructured":"Searle SR, Speed FM, Milliken GA. Population marginal means in the linear model: an alternative to least squares means. Am Stat. 1980;34:216\u201321. https:\/\/doi.org\/10.1080\/00031305.1980.10483031.","journal-title":"Am Stat"},{"issue":"11","key":"6375_CR20","first-page":"925","volume":"101","author":"H Welti","year":"1981","unstructured":"Welti H. Thromboembolytic prophylaxis using physiotherapy with and without low doses of heparin in gynecology and obstetrics. Results of a controlled and randomized multi-cancer study. Rev Med Suisse Romande. 1981;101(11):925\u201334.","journal-title":"Rev Med Suisse Romande"},{"issue":"4","key":"6375_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000269315","volume":"22","author":"A Studer-Sch\u00e4r","year":"1982","unstructured":"Studer-Sch\u00e4r A. Hemorrhages caused by \u201clow dose\u201d heparin and placebo (NaCl solution) in surgical gynecology. Gynakol Rundsch. 1982;22(4):241\u20138.","journal-title":"Gynakol Rundsch"},{"issue":"9","key":"6375_CR22","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","volume":"108","author":"TE Warkentin","year":"2006","unstructured":"Warkentin TE, Sheppard JA, Sigouin CS, Kohlmann T, Eichler P, Greinacher A. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood. 2006;108(9):2937\u201341.","journal-title":"Blood"},{"issue":"2","key":"6375_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jth.14359","volume":"17","author":"T Gallo","year":"2019","unstructured":"Gallo T, Curry SC, Padilla-Jones A, Heise CW, Ramos KS, Woosley RL, et al. A computerized scoring system to improve assessment of heparin-induced thrombocytopenia risk. J Thromb Haemost. 2019;17(2):383\u20138.","journal-title":"J Thromb Haemost"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-025-06375-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T13:17:56Z","timestamp":1774703876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-025-06375-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["6375"],"URL":"https:\/\/doi.org\/10.1007\/s00192-025-06375-9","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was deemed exempt by the University Hospitals Cleveland Medical Center Institutional Review Board given the deidentified nature of the data (#20201629).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Society of Gynecologic Surgeons 50th Annual Scientific Meeting, Orlando, FL, USA, March 24\u201327, 2024.Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction Winter Meeting 2024, Fort Lauderdale, FL, USA, February 20\u201324, 2024.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior Presentation"}},{"value":"DS Consultant: Caldera Medical; Research Support: Eunice Kennedy Shriver National Institute of Child Health and Human Development, Agency for Healthcare Research and Quality, National Institute of Aging, Renalis, Vikor Scientific, Thermo Fisher, Medtronic, Axonics, Bluewinds Revi; Advisory Board\/Equity: CollaMedix.AH Consultant: Sumitomo Pharma; Research Support: Eunice Kennedy Shriver National Institute of Child Health and Human Development, Agency for Healthcare Research and Quality, Bluewinds Revi; Equity: CollaMedix.HHB, MAS and SPR report no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}